khedezla
Pharmaranks rates Khedezla 3.5/5 for recall safety — an independent score from its FDA recall history and its manufacturer's record. Khedezla (Desvenlafaxine) is a serotonin and norepinephrine reuptake inhibitor used to treat Major Depressive Disorder.
Desvenlafaxine · by Osmotica Pharm US
Available as a generic: Desvenlafaxine
Based on 1 source · Recall-safety score from FDA recall history — this product's own recalls and its manufacturer's record. Not an efficacy or quality rating. methodology →
Key facts
- Active ingredient
- Desvenlafaxine
- Form
- Tablet, extended release
- Strength
- Desvenlafaxine 100MG · Desvenlafaxine 50MG
- Type
- Prescription (Rx)
- Brand or generic
- Brand-name
- May treat
- major depressive disorder
- Manufacturer
- Osmotica Pharm US
- What the pharmacy pays
- ~$115.24 for 30 — not your price
- FDA application
- NDA204683
- Availability
- Discontinued (per FDA)
Drug class
How this class works, per Duloxetine - StatPearls - NCBI Bookshelf.
May treat (source: NIH RxClass)
See how Khedezla ranks — best-rated serotonin and norepinephrine reuptake inhibitor for:
Dosage forms
Tablet, extended release
The forms currently marketed in the U.S., per the FDA National Drug Code Directory.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Frequently asked questions
- What does Khedezla treat?
- Khedezla (Desvenlafaxine) may be used to treat major depressive disorder, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.
- How does Khedezla work?
- Khedezla is a serotonin and norepinephrine reuptake inhibitor. SNRIs slow the reabsorption of two brain chemicals, serotonin and norepinephrine, back into nerve cells. This leaves more of both available in the gaps between neurons to keep signaling, which can improve mood, anxiety, and certain types of chronic pain.
- How is Khedezla rated?
- pharmaranks gives Khedezla a composite score of 3.5 out of 5, currently based on 1 weighted source (FDA regulatory recall-safety data weighted highest). See our methodology at /how-we-rate.
- How much does Khedezla cost?
- Nobody can tell you what you will pay — your price is set by your insurer's formulary, your deductible and the pharmacy's markup, and none of those are published. What IS published is what the pharmacy paid to acquire it: about $115.24 for 30, per the CMS NADAC survey. Treat that as the floor, not the quote — ask the pharmacist for the cash price as well as your copay, because for cheap generics the cash price often wins. Pharmacies pay less for a same-class option, Cymbalta — about $3.41 on the same basis.
- Is there a coupon or discount for Khedezla?
- pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Khedezla. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
- Who makes Khedezla?
- Khedezla is marketed by Osmotica Pharm US. You can see Osmotica Pharm US's full profile, rating, and other products on pharmaranks.
- Is Khedezla a brand-name or generic drug?
- Khedezla is a brand-name product with the active ingredient Desvenlafaxine. Lower-cost generic equivalents containing Desvenlafaxine are available — ask your pharmacist.
- Is Khedezla available over the counter?
- No. Khedezla is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
- What forms does Khedezla come in?
- Khedezla is currently marketed as tablet, extended release, per the FDA's National Drug Code Directory.
- What class of drug is Khedezla?
- Khedezla is classified as serotonin and norepinephrine reuptake inhibitor, per the FDA's Established Pharmacologic Class.
- Is Khedezla FDA-registered?
- Khedezla is on record with the U.S. FDA under application number NDA204683. You can verify this on its official FDA label.
- Has Khedezla been recalled by the FDA?
- Khedezla has no FDA recalls recorded under its own application in the openFDA enforcement database. Its recall-safety score reflects its manufacturer's overall recall record. This is general reference, not medical advice — check the FDA recall database for the latest alerts.
- Is Khedezla safe?
- There's no single safe-or-not verdict. pharmaranks gives Khedezla a recall-safety score of 70/100, based on its FDA recall history (no recalls under its own FDA application) — not an efficacy or side-effect rating. Review its FDA-label side effects and warnings before use, and always consult a licensed professional.
Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
Reviews
No reviews yet. Be the first to write one.
People also viewed
fetzima
Levomilnacipran Hydrochloride
levomilnacipran hydrochloride
Levomilnacipran Hydrochloride
savella
Milnacipran Hydrochloride
desvenlafaxine succinate
Desvenlafaxine Succinate
cymbalta
Duloxetine Hydrochloride
drizalma sprinkle
Duloxetine Hydrochloride
Compare Khedezla head-to-head
More serotonin and norepinephrine reuptake inhibitor drugs
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.
khedezla
70/100